Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|November 17, 2020
The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospitalAnil-Martin Sinha, Jens Bense, Wolfgang Hohenforst-SchmidtJournal of Thoracic Disease|January 10, 2019
Therapeutic bronchoscopy in the era of genotype directed lung cancer managementArjun Mohan, Kassem Harris, Mark R Bowling, et al.Clinical and Translational Medicine|January 20, 2017
Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?Paul Zarogoulidis, Mina Gaga, Haidong Huang, et al.Drug Design, Development and Therapy|May 11, 2013
Successful management of an inadvertent excessive treprostinil overdoseWolfgang Hohenforst-Schmidt, Juergen Hornig, Norbert Friedel, et al.Translational Lung Cancer Research|March 26, 2015
Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancerPaul Zarogoulidis, Kaid Darwiche, George Kalamaras, et al.Respiratory Medicine Case Reports|August 11, 2017
Innovative use of a Montgomery cannula in the bronchoscopic management of tracheal stenosis and failed tracheostomy decannulationHaidong Huang, Changming Chen, Harmeet Bedi, et al.Future Oncology (London, England)|August 2, 2013
Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancerPaul Zarogoulidis, Kaid Darwiche, Wolfgang Hohenforst-Schmidt, et al.Therapeutics and Clinical Risk Management|June 6, 2017
A retrograde y-stenting of the trachea for treatment of mediastinal fistula in an unusual situationWolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Michael Steinheimer, et al.British Journal of Cancer|May 28, 2020
Producing the appropriate model and drug for intratumoural ablationChristoforos Kosmidis, Chrysanthi Sardeli, Paul Zarogoulidis, et al.Therapeutics and Clinical Risk Management|March 31, 2017
Second-line afatinib administration in an elderly patient with squamous cell carcinomaWolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Michael Steinheimer, et al.Pageof 16